Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201201069 Principal Investigator: Vij, Ravi
Title: A Multicenter Phase 2 Study of the Bruton’s Tyrosine Kinase (Btk) Inhibitor, PCI-32765, in Subjects with Relapsed or Relapsed and Refractory Multiple Myeloma
Phase: II Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purposes of this study include finding out if the study drug, given once daily by mouth, will slow or stop your cancer from getting worse, and whether the study drug has side effects.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)